Takeda Pharmaceutical (TAK) Gross Margin Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 631.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -673.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -675.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -838.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 33.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -344.00 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 596.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -673.00 |
| Dec 31, 2025 | 398.00 |
| Sep 30, 2025 | -14,717.00 |
| Jun 30, 2025 | -519.00 |
| Mar 31, 2025 | -192.00 |
| Dec 31, 2024 | -505.00 |
| Sep 30, 2024 | -131.00 |
| Jun 30, 2024 | -988.00 |
| Mar 31, 2024 | 87.00 |
| Dec 31, 2023 | -614.00 |
| Sep 30, 2023 | -16,659.00 |
| Jun 30, 2023 | -423.00 |
| Mar 31, 2023 | -488.00 |
| Sep 30, 2022 | -6.65 Mn |
| Jun 30, 2022 | 603.00 |
| Mar 31, 2022 | -331.00 |
| Dec 31, 2021 | -349.00 |
| Jun 30, 2021 | 140.00 |
| Mar 31, 2021 | -525.00 |
| Dec 31, 2020 | -110.00 |